Table I.
Distribution of patient management and follow-up according to multiplex polymerase chain reaction (mPCR) results
| mPCR results (N=157) | Single room | Double room | Antibiotic treatment | Treatment with oseltamivir | ICU admission | Length of stay (days), median (IQR) |
|---|---|---|---|---|---|---|
| Negative (N=78) | 32 (41%) | 46 (59%) | 23 (29%) | 2 (2%) | 12 (15%) | 2 (1–8) |
| Influenza A (N=46a) | 37 (80%) | 9 (19%) | 20 (44%) | 45 (98%) | 17 (21%) | 3 (1–7) |
| RSV (N=12b) | 9 (75%) | 3 (25%) | 5 (42%) | 3 (25%) | 1 (11%) | 2 (1–8) |
| Rhinovirus (N=12) | 6 (50%) | 6 (50%) | 3 (33%) | 1 (11%) | 10 (22%) | 3 (2–9) |
| Others (N=9c) | 7 (78%) | 2 (22%) | 8 (88%) | 0 (0%) | 6 (66%) | 6 (0–23) |
ICU, intensive care unit; RSV, respiratory syncytial virus; IQR, interquartile range.
a
Including two codetections with RSV and two with a coronavirus.
b
Including one codetection with a rhinovirus.
c
Including two coronaviruses, three Mycoplasma pneumoniae and four human metapneumoviruses.